Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06128239 · ClinicalTrials.gov registry record · NA

Comparing Suicide Prevention Interventions to Guide Follow-up Care: The SPRING Trial

A NA study of Suicide and Suicide Prevention, sponsored by St. Luke's Health System, Boise, Idaho.

Active
Registry status
NA
Development phase
854
Enrollment target
1
Study location

NCT06128239: Active NA study of Suicide and Suicide Prevention, sponsored by St. Luke's Health System, Boise, Idaho.

NCT06128239 is a NA study of Suicide and Suicide Prevention that is active but no longer recruiting, run by St. Luke's Health System, Boise, Idaho. The registered enrollment target is 854 participants, below the 6,981-participant average among 92 other Suicide trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06128239, a NA study of Suicide and Suicide Prevention, is active but no longer recruiting, sponsored by St. Luke's Health System, Boise, Idaho.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
854 participants
Enrollment target
1
Study location

Study Summary

Pragmatic randomized controlled trial to compare the effectiveness of two-way Caring Contacts text messages vs. one-way Caring Contacts text messages vs. enhanced usual care for suicide prevention in adults and adolescents.

Primary Outcome

Measured using the Harkavy-Asnis Suicide Scale (HASS) Active Suicidal Behavior Sub-Scale. The HASS has been validated for self-report, with strong psychometric properties in adolescents and adults. This measure asks about the frequency of suicide attempt planning, and actual and aborted/interrupted suicide attempts. Participants respond using the Likert scale response options used by Asarnow et al.'s validation study, modified to fit the survey time period (past six months at baseline/12-month o

Interventions

  • BEHAVIORAL Caring Contacts

Study Locations (1)

Idaho

  • St. Luke's Health System - Boise

Trial Details

FieldValue
Enrollment Target 854 participants
Start Date 2023-12-29
Est. Completion 2026-03-31
Phase NA

What the registry record for NCT06128239 still lists

NCT06128239 is an interventional study that assigns participants to a tested intervention. The registered 854 participants enrollment target is mid-sized for trials with a published cap, below the 6,981-participant average among 92 other Suicide trials with a reported enrollment target (88% lower).

The record links to 3 conditions, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which Caring Contacts is the first listed.

NCT06128239 reports a single indexed study location in Idaho.

Frequently Asked Questions

What is clinical trial NCT06128239 about?

NCT06128239 is a clinical study titled "Comparing Suicide Prevention Interventions to Guide Follow-up Care: The SPRING Trial". Pragmatic randomized controlled trial to compare the effectiveness of two-way Caring Contacts text messages vs. one-way Caring Contacts text messages vs. enhanced usual care for suicide prevention in adults and adolescents.

What is the current status of trial NCT06128239?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 854 participants. The study started on 2023-12-29. Estimated completion is 2026-03-31.

What conditions does trial NCT06128239 study?

This clinical trial studies the following conditions: Suicide, Suicide Prevention, Suicide and Self-harm.

What interventions are being tested in trial NCT06128239?

The interventions under investigation include: Caring Contacts (BEHAVIORAL).

Who is sponsoring clinical trial NCT06128239?

This trial is sponsored by St. Luke's Health System, Boise, Idaho, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06128239 being conducted?

This trial has 1 study location across Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06128239's enrollment target sits among peer trials

854 16th of 92 higher than 77 of 92 other Suicide trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07005102 · 854 participants · Phase 2

    A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

  • NCT07290491 · 854 participants · Phase 3

    Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies

  • NCT05108896 · 855 participants · NA

    Aspiration in Acute Respiratory Failure Survivors 2

  • NCT06231485 · 856 participants · NA

    Socialization To Enrich Participation & Support Sexuality for Young People With I/DD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06128239, the US trial registry maintained by the National Library of Medicine. NCT06128239 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.